Adult Prophylaxis of thromboembolic disorders in general surgery 0.3 mL SC daily 2-4 hr pre-op for at least 7 days.
Orthopaedic surgery ≥70 kg 0.4 mL SC 12 hr pre- & post-op then once daily on day 3, 0.6 mL from day 4 onwards,
50-69 kg 0.3 mL 12 hr SC pre- & post-op then once daily on day 3, 0.4 mL from day 4 onwards,
<50 kg 0.2 mL SC 12 hr pre- & post-op then once daily on day 3, 0.3 mL from day 4 onwards. Min duration: 10 days.
High-risk medical patient, immobilised due to acute illness or hospitalised in ICU >70 kg 0.6 mL SC once daily,
≤70 kg 0.4 mL SC once daily.
Thromboembolic disorders ≥90 kg 0.9 mL SC bd,
80-89 kg 0.8 mL SC bd,
70-79 kg 0.7 mL SC bd,
60-69 kg 0.6 mL SC bd,
50-59 kg 0.5 mL SC bd,
<50 kg 0.4 mL SC bd. Usual duration: 10 days.
Prevention of clotting during haemodialysis for patient w/o risk of haemorrhage Administered as single dose inj into arterial line at start of each session,
≥70 kg 0.6 mL,
50-69 kg 0.4 mL,
<50 kg 0.3 mL.
Unstable angina & non-Q wave MI Initial dose given as IV bolus & subsequent doses as SC inj 12 hrly in combination w/ aspirin 325 mg daily,
≥100 kg 1 mL,
90-99 kg 0.9 mL,
80-89 kg 0.8 mL,
70-79 kg 0.7 mL,
60-69 kg 0.6 mL,
50-59 kg 0.5 mL,
<50 kg 0.4 mL.
Sign Out
 2_850 anti-Xa IU1d2c013a-6763-4689-9c01-abfb0080adc2.GIF)
